During the past decade, Malopolskie Centrum Alergologii conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Malopolskie Centrum Alergologii" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Anergis" with 1 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored, "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Malopolskie Centrum Alergologii" are "Asthma" (5 trials), "Allergic Rhinitis" (1 trials), "COPD" (1 trials), "Chronic Spontaneous Urticaria" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Malopolskie Centrum Alergologii" in a lesser frequency.

Most popular intervention types in "Malopolskie Centrum Alergologii" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Lebrikizumab" (2 trials), "AllerT" (1 trials), "GB001" (1 trials) and "MSTT1041A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Malopolskie Centrum Alergologii" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Malopolskie Centrum Alergologii". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Malopolskie Centrum Alergologii, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Malopolskie Centrum Alergologii, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".